Bio Tonsilla Phase Liquid
NDC Package 43742-1600-1
Package Information
Bio Tonsilla Phase (dulcamara, echinacea (angustifolia), aesculus hippocastanum, antimonium tartaricum, ascorbicum acidum, coccus cacti, galium aparine, gentiana lutea, geranium robertianum, pulsatilla (pratensis), sarcolacticum acidum, acetylcholine chloride, mannose, conium maculatum, lymph node (suis), sulphur, calcarea phosphorica, funiculus umbilicalis suis, hepar suis, hypothalamus suis, medulla ossis suis, spleen (suis), cortisone aceticum, glandula suprarenalis suis, mercurius solubilis, thyroidinum (suis),) liquids is for the temporary relief of symptoms such as sore throat, pain, swelling, and inflammation.****These statements are based upon traditional homeopathic principles. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-1600.
Identification & Billing
Clinical Specifications
- SOLANUM DULCAMARA TOP 6 [hp_X]/mL
- ECHINACEA ANGUSTIFOLIA WHOLE 6 [hp_X]/mL
- HORSE CHESTNUT 6 [hp_X]/mL
- ANTIMONY POTASSIUM TARTRATE 28 [hp_X]/mL
- ASCORBIC ACID 8 [hp_X]/mL
- PROTORTONIA CACTI 13 [hp_X]/mL
- GALIUM APARINE WHOLE 4 [hp_X]/mL
- GENTIANA LUTEA ROOT 6 [hp_X]/mL
- GERANIUM ROBERTIANUM WHOLE 6 [hp_X]/mL
- PULSATILLA PRATENSIS WHOLE 6 [hp_X]/mL
- LACTIC ACID, L- 6 [hp_X]/mL
- ACETYLCHOLINE CHLORIDE 6 [hp_X]/mL
- MANNOSE, D- 6 [hp_X]/mL
- CONIUM MACULATUM FLOWERING TOP 13 [hp_X]/mL
- SUS SCROFA LYMPH 10 [hp_X]/mL
- SULFUR 6 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE 6 [hp_X]/mL
- SUS SCROFA UMBILICAL CORD 4 [hp_X]/mL
- PORK LIVER 8 [hp_X]/mL
- SUS SCROFA HYPOTHALAMUS 13 [hp_X]/mL
- SUS SCROFA BONE MARROW 10 [hp_X]/mL
- SUS SCROFA SPLEEN 10 [hp_X]/mL
- CORTISONE ACETATE 8 [hp_X]/mL
- SUS SCROFA ADRENAL GLAND 10 [hp_X]/mL
- MERCURIUS SOLUBILIS 13 [hp_X]/mL
- SUS SCROFA THYROID 28 [hp_X]/mL
- BARIUM CARBONATE 10 [hp_X]/mL
- SUS SCROFA TONSIL 10 [hp_X]/mL
- Ascorbic Acid - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Cations, Divalent - [CS]
- Cholinergic Agonists - [MoA] (Mechanism of Action)
- Cholinergic Receptor Agonist - [EPC] (Established Pharmacologic Class)
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Vitamin C - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 43742 - Deseret Biologicals, Inc.
- 43742-1600 - Bio Tonsilla Phase
- 43742-1600-1 - 30 mL in 1 BOTTLE, DROPPER
- 43742-1600 - Bio Tonsilla Phase
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43742-1600-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Bio Tonsilla Phase, a human over the counter drug labeled by Deseret Biologicals, Inc.. This liquid is formulated for oral use and contains solanum dulcamara top; echinacea angustifolia whole; horse chestnut; antimony potassium tartrate; ascorbic acid; protortonia cacti; galium aparine whole; gentiana lutea root; geranium robertianum whole; pulsatilla pratensis whole; lactic acid, l-; acetylcholine chloride; mannose, d-; conium maculatum flowering top; sus scrofa lymph; sulfur; tribasic calcium phosphate; sus scrofa umbilical cord; pork liver; sus scrofa hypothalamus; sus scrofa bone marrow; sus scrofa spleen; cortisone acetate; sus scrofa adrenal gland; mercurius solubilis; sus scrofa thyroid; barium carbonate; sus scrofa tonsil as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on October 29, 2019. The current certification is valid through December 31, 2026.
How is this Deseret Biologicals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742160001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.